
Pfizer markets Vyndamax as the "only once-daily capsule". The evidence says otherwise.
Patients are not informed that a cheaper rival pill exists, or that Pfizer paid the support group it recommends.
Read the full report →
Patients are not informed that a cheaper rival pill exists, or that Pfizer paid the support group it recommends.
Read the full report →Full methodology, company profiles and enforcement findings: PDF report available on the index page.
Download Report